These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 10758283

  • 1. N-Butyl-N-methyl-11-(3'-hydroxy-21', 17'-carbolactone-19'-nor-17'alpha-pregna-1',3', 5'(10')-trien-7'alpha-yl)-undecanamide: an inhibitor of type 2 17beta-hydroxysteroid dehydrogenase that does not have oestrogenic or androgenic activity.
    Sam K, Labrie F, Poirier D.
    Eur J Med Chem; 2000 Feb; 35(2):217-25. PubMed ID: 10758283
    [Abstract] [Full Text] [Related]

  • 2. Steroidal spiro-gamma-lactones that inhibit 17 beta-hydroxysteroid dehydrogenase activity in human placental microsomes.
    Sam KM, Auger S, Luu-The V, Poirier D.
    J Med Chem; 1995 Oct 27; 38(22):4518-28. PubMed ID: 7473580
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Spironolactone-related inhibitors of type II 17beta-hydroxysteroid dehydrogenase: chemical synthesis, receptor binding affinities, and proliferative/antiproliferative activities.
    Tremblay MR, Luu-The V, Leblanc G, Noël P, Breton E, Labrie F, Poirier D.
    Bioorg Med Chem; 1999 Jun 27; 7(6):1013-23. PubMed ID: 10428369
    [Abstract] [Full Text] [Related]

  • 5. A 6beta-(thiaheptanamide) derivative of estradiol as inhibitor of 17beta-hydroxysteroid dehydrogenase type 1.
    Poirier D, Dionne P, Auger S.
    J Steroid Biochem Mol Biol; 1998 Jan 27; 64(1-2):83-90. PubMed ID: 9569013
    [Abstract] [Full Text] [Related]

  • 6. Inhibitors of type II 17beta-hydroxysteroid dehydrogenase.
    Poirier D, Bydal P, Tremblay MR, Sam KM, Luu-The V.
    Mol Cell Endocrinol; 2001 Jan 22; 171(1-2):119-28. PubMed ID: 11165020
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of type 2 17beta-hydroxysteroid dehydrogenase by estradiol derivatives bearing a lactone on the D-ring: structure-activity relationships.
    Bydal P, Auger S, Poirier D.
    Steroids; 2004 May 22; 69(5):325-42. PubMed ID: 15219411
    [Abstract] [Full Text] [Related]

  • 8. 1H and 13C nuclear magnetic resonance assignments and stereochemistry of N-n-butyl-N-methyl-11-(16'alpha-chloro-3',17'beta- and 17'alpha-dihydroxyestra-1',3',5'(10')-trien-7'alpha-yl) undecanamide.
    Dionne P, Singh SM, Labrie F.
    Steroids; 1994 Aug 22; 59(8):493-7. PubMed ID: 7985212
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis and in vitro evaluation of 4-androstene-3,17-dione/adenosine hybrid compounds as bisubstrate inhibitors of type 3 17beta-hydroxysteroid dehydrogenase.
    Bérubé M, Laplante Y, Poirier D.
    Med Chem; 2006 Jul 22; 2(4):329-47. PubMed ID: 16848745
    [Abstract] [Full Text] [Related]

  • 10. Effects of phytoestrogens on aromatase, 3beta and 17beta-hydroxysteroid dehydrogenase activities and human breast cancer cells.
    Le Bail JC, Champavier Y, Chulia AJ, Habrioux G.
    Life Sci; 2000 Feb 25; 66(14):1281-91. PubMed ID: 10755463
    [Abstract] [Full Text] [Related]

  • 11. Parallel solid-phase synthesis of 3beta-peptido-3alpha-hydroxy-5alpha-androstan-17-one derivatives for inhibition of type 3 17beta-hydroxysteroid dehydrogenase.
    Maltais R, Luu-The V, Poirier D.
    Bioorg Med Chem; 2001 Dec 25; 9(12):3101-11. PubMed ID: 11711285
    [Abstract] [Full Text] [Related]

  • 12. Overview of a rational approach to design type I 17beta-hydroxysteroid dehydrogenase inhibitors without estrogenic activity: chemical synthesis and biological evaluation.
    Tremblay MR, Poirier D.
    J Steroid Biochem Mol Biol; 1998 Aug 25; 66(4):179-91. PubMed ID: 9744515
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of 7-hydroxy-flavones as inhibitors of oestrone and oestradiol biosynthesis.
    Vinh TK, Nicholls PJ, Kirby AJ, Simons C.
    J Enzyme Inhib; 2001 Nov 25; 16(5):417-24. PubMed ID: 11916147
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
    Li S, Lévesque C, Geng CS, Yan X, Labrie F.
    Breast Cancer Res Treat; 1995 May 25; 34(2):147-59. PubMed ID: 7647332
    [Abstract] [Full Text] [Related]

  • 15. Inhibitors of 17 beta-hydroxysteroid dehydrogenases.
    Poirier D.
    Curr Med Chem; 2003 Mar 25; 10(6):453-77. PubMed ID: 12570693
    [Abstract] [Full Text] [Related]

  • 16. 3Beta-alkyl-androsterones as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase: inhibitory potency in intact cells, selectivity towards isoforms 1, 2, 5 and 7, binding affinity for steroid receptors, and proliferative/antiproliferative activities on AR+ and ER+ cell lines.
    Ngatcha BT, Laplante Y, Labrie F, Luu-The V, Poirier D.
    Mol Cell Endocrinol; 2006 Mar 27; 248(1-2):225-32. PubMed ID: 16359782
    [Abstract] [Full Text] [Related]

  • 17. Androgen formation and metabolism in the pulmonary epithelial cell line A549: expression of 17beta-hydroxysteroid dehydrogenase type 5 and 3alpha-hydroxysteroid dehydrogenase type 3.
    Provost PR, Blomquist CH, Godin C, Huang XF, Flamand N, Luu-The V, Nadeau D, Tremblay Y.
    Endocrinology; 2000 Aug 27; 141(8):2786-94. PubMed ID: 10919264
    [Abstract] [Full Text] [Related]

  • 18. Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer.
    Le Lain R, Nicholls PJ, Smith HJ, Maharlouie FH.
    J Enzyme Inhib; 2001 Jan 27; 16(1):35-45. PubMed ID: 11496833
    [Abstract] [Full Text] [Related]

  • 19. STX2171, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer model.
    Day JM, Foster PA, Tutill HJ, Schmidlin F, Sharland CM, Hargrave JD, Vicker N, Potter BV, Reed MJ, Purohit A.
    Endocr Relat Cancer; 2013 Feb 27; 20(1):53-64. PubMed ID: 23132791
    [Abstract] [Full Text] [Related]

  • 20. Regulation of sex steroid formation by interleukin-4 and interleukin-6 in breast cancer cells.
    Turgeon C, Gingras S, Carrière MC, Blais Y, Labrie F, Simard J.
    J Steroid Biochem Mol Biol; 1998 Apr 27; 65(1-6):151-62. PubMed ID: 9699868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.